IP Library Granted Patent US 8,374,665
Granted Patent B2
US 8,374,665 · App. 12/106,969 · Granted Feb 12, 2013

Tissue profile wellness monitor

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,374,665
App. No.
12/106,969
Granted
Feb 12, 2013
Kind
B2
Abstract

A tissue profile wellness monitor measures a physiological parameter, generates a tissue profile, defines limits and indicates when the tissue profile exceeds the defined limits. The physiological parameter is responsive to multiple wavelengths of optical radiation after attenuation by constituents of pulsatile blood flowing within a tissue site. The tissue profile is responsive to the physiological parameter. The limits are defined for at least a portion of the tissue profile.

Claims (47)

1. A physiological monitoring method comprising:

emitting light of eight or more wavelengths into tissue of a patient, the eight or more wavelengths responsive to pulsatile blood flowing within the tissue of the patient;

detecting the emitted light after attenuation by the tissue of the patient;

continuously generating a tissue profile responsive to absorption of the emitted wavelengths using a processor in real time,

continuously analyzing the tissue profile using the processor to determine if a change in the shape of the tissue profile has occurred;

indicating a wellness condition of the patient based on the analysis of the tissue profile.

2. The physiological monitoring method according to claim 1 wherein generating comprises:

measuring values at each of the emitted wavelengths; and

defining values corresponding to at least a portion of a wavelength spectrum between the emitted wavelengths based upon known characteristics of the tissue site.

3. The physiological monitoring method according to claim 2 wherein analyzing comprises:

setting a limit corresponding to the tissue profile; and

specifying an output corresponding to a comparison of the tissue profile to the set limit.

4. The physiological monitoring method according to claim 3 wherein indicating comprises generating at least one of a display, an alarm, diagnostic and a control.

5. The physiological monitoring method according to claim 3 wherein the setting a limit comprises defining at least one of a boundary and a maximum rate of change for at least a portion of the tissue profile.

6. The physiological monitoring method according to claim 5 wherein the indicating comprises generating at least one of an audible and visual alarm in response to at least a portion of the tissue profile exceeding the set limit.

7. The physiological monitoring method according to claim 2 wherein the measuring comprises calculating a normalized plethysmograph (NP) for each of the emitted wavelengths with respect to the NP at one of the emitted wavelengths.

8. A physiological monitoring method comprising:

emitting optical radiation of three or more wavelengths into the tissue of a patient;

detecting the optical radiation after attenuation of the light by the tissue of the patient;

continuously measuring a normalized plethysmograph (NP) at each of multiple wavelengths of the optical radiation so as to generate a tissue profile, the NP being responsive to attenuation of the optical radiation by constituents of pulsatile blood flowing within a tissue site illuminated by the optical radiation;

analyzing the tissue profile to determine if the shape of the tissue profile indicates an abnormal condition of the patient; and

outputting at least one of a display, alarm, diagnostic and control according to the testing results.

9. The physiological monitoring method according to claim 8 wherein analyzing comprises:

dividing the profile into a head portion at wavelengths less than a normalizing wavelength and a tail portion at wavelengths greater than a normalizing wavelength; and

evaluating the tail portion separately from the head portion.

10. The physiological monitoring method according to claim 9 wherein the evaluating comprises:

comparing the head portion against a head boundary; and

comparing the tail portion against a tail boundary.

11. The physiological monitoring method according to claim 10 wherein the evaluating comprises:

comparing the head portion against a head trend limit; and

comparing the tail portion against a tail trend limit.

12. The physiological monitoring method according to claim 11 wherein outputting comprises:

activating a first signal indicative of normalcy so long as the head portion is within the head boundary and changing less than the head trend limit and the tail portion is within the tail boundary and changing less than the tail trend limit;

activating a second signal indicative of caution when at least one of the head portion is changing faster than the head trend limit and the tail portion is changing faster than the tail trend limit; and

activating a third signal indicative of high alert when at least one of the head portion is outside the head boundary and the tail portion is outside the tail boundary.

13. A physiological monitoring method comprising:

emitting three or more wavelengths of light into a tissue site of a patient including pulsating blood;

detecting the light after attenuation by the tissue site;

measuring a physiological parameter responsive to multiple wavelengths of optical radiation after attenuation by constituents of pulsatile blood flowing within a tissue site;

continuously generating a tissue profile in response to the physiological parameter using a processor;

defining shape change limits for at least a portion of the tissue profile; and

indicating when the tissue profile changes shape and exceeds the defined limits.

14. The physiological monitoring method according to claim 13 wherein the defining limits comprise setting for at least a portion of the tissue profile at least one of a boundary and a trend limit.

15. The physiological monitoring method according to claim 14 further comprising:

determining a normalizing wavelength so as to divide the tissue profile into a first portion at wavelength of less than the normalizing wavelength and a second portion at wavelength of greater than the normalizing wavelength; and

defining limits for each of the first portion and the second portion.

16. The indicator method according the claim 15 wherein said normalized wavelength is 700 nm.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 9, 2016
From: CERCACOR LABORATORIES, INC.
To: MASIMO CORPORATION
Reel/Frame 038049/0074 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 4, 2012
From: LAMEGO, MARCELO
To: MASIMO LABORATORIES, INC.
Reel/Frame 029400/0608 →
CHANGE OF NAME Recorded May 11, 2012
From: MASIMO LABORATORIES, INC.
To: CERCACOR LABORATORIES, INC.
Reel/Frame 028192/0453 →